Critical Stocks Alerts: Significant Insider Trade in Ascena Retail Group, Dyax Corp, United Therapeutics Corp, Bank of America, Citigroup, and Exxon Mobil
PHOENIX, Jan. 19, 2016 /PRNewswire/ -- Pennystocksinsiders.com (PSI) released stock alert on companies with significant trade made by company insiders such as CEO, CFO, and senior officers. When a company catches your attention, it is a good idea to start your research with the larger transaction values first.
The importance of the relative size of an insider's purchase should not be downplayed in favor of the actual dollar value of the trade. Most insiders are not chairmen with multi-million-dollar bonuses. The average vice president and chief financial officer at a company may make a comfortable living, but for many a $10,000 trade is still serious money. The transaction value may look puny beside all the other trades you see on a given day, but it does not mean it is not significant.
One should give more credence to the 5,000-share purchase by a vice president if it doubles his total holdings compared to a 50,000-share purchase by a chairman who may have millions of shares. Many of the vice president's investments are very well representing a larger share of his net worth and the rest of us should be aware when insiders are investing in this manner.
Ascena Retail Group, Inc. (NASDAQ:ASNA): Senior Officer (EVP, CFO): Giammatteo Robert acquired 5,000 Common (Non-Derivative security at $8.212) on Jan 14, 2016. Direct holding 6,678 shares after transaction. Holdings increased by 297.97%.
Read full report: http://www.Pennystocksinsiders.com/PR5/011916A/ASNA/AscenaRetailGroup.pdf
Dyax Corp (NASDAQ:DYAX): Senior Officer (EVP & Chief Financial Officer): MIGAUSKY GEORGE V acquired 142,239 Common Stock (Non-Derivative security at $1.910) on Jan 12, 2016. Direct holding 362,964 shares after transaction. Holdings increased by 64.44%.
Read full report:
http://www.Pennystocksinsiders.com/PR5/011916A/DYAX/DyaxCorp.pdf
United Therapeutics Corp (NASDAQ:UTHR): President & Co-CEO: JEFFS ROGER acquired 3,000 Common Stock (Non-Derivative security at $65.800) on Jan 13, 2016. Direct holding 3,559 shares after transaction. Holdings increased by 536.67%.
Read full report:
http://www.Pennystocksinsiders.com/PR5/011916A/UTHR/UnitedTherapeutics.pdf
Today Pennystocksinsiders.com also observed abnormal trade volume for the following companies; insiders may be involved in trading these companies. It will take some time for insiders to report their trades. Read these reports and add these companies into your Insider Trade Radar.
Bank Of America (NYSE:BAC)
Read Full Report:
http://www.Pennystocksinsiders.com/PR5/011916A/BAC/BankOfAmerica.pdf
Citigroup (NYSE:C)
Read Full Report:
http://www.Pennystocksinsiders.com/PR5/011916A/C/Citigroup.pdf
Exxon Mobil (NYSE:XOM)
Read Full Report:
http://www.Pennystocksinsiders.com/PR5/011916A/XOM/ExxonMobil.pdf
Insider Filing Source Reference: All observations, analysis and reports are based on public information released by the U.S. Securities and Exchange Commission.
About Pennystocksinsiders.com:
Pennystocksinsiders.com features a team of experienced data analysts striving to provide the investment community with the tools, software, and data necessary to carry out more effective investment research.
Important Disclaimer:
Please visit Pennystocksinsiders.com/disclaimers/index.php for details.
Logo - http://photos.prnewswire.com/prnh/20160118/323329
SOURCE Pennystocksinsiders.com
Share this article